Recruiting NA Tennis Elbow

New treatment option for Tennis Elbow

Official title Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and Without Tennis Elbow (TE)

ClinicalTrials.gov ID: NCT07178288

What this study is testing

What it's testing
This study at Hashemite University looks at how people with and without tennis elbow (AKA lateral elbow tendinopathy) feel pressure pain and how their bodies briefly "turn down" pain after a cold stimulus. Participants complete brief questionnaires (basic demographics without names, a tennis-elbow symptom form, and a physical-activity form) and then have their pressure-pain threshold (PPT) tested with a handheld device that slowly increases pressure on standard spots near the elbow and wrist; they say when it first becomes painful.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages up to 60. Healthy volunteers may be eligible.

You may be able to join if

  • TE Group Patients with Tennis Elbow confirmed at initial assessment by the Primary Investigator (PI) Unilateral elbow pain \> 6 weeks duration...
  • Palpation of the lateral epicondyle
  • Isometric testing of the wrist extensors
  • Middle finger extension test
  • Passive stretch of wrist extensors

You likely can't join if

  • History of chronic pain conditions (e.g. fibromyalgia, irritable bowel
  • syndrome, temporomandibular dysfunction, migraines)
  • Neurological or sensory dysfunction (especially in the upper limbs)
  • History of chronic musculoskeletal pain (e.g. arthritis, chronic low back
  • pain)
  • Contraindications to cold application (i.e. Reynaud's disease, diabetes)
See the full eligibility criteria
Who can join
  • TE Group Patients with Tennis Elbow confirmed at initial assessment by the Primary Investigator (PI) Unilateral elbow pain \> 6 weeks duration reproduced on at least two of the following tests:
  • Palpation of the lateral epicondyle
  • Isometric testing of the wrist extensors
  • Middle finger extension test
  • Passive stretch of wrist extensors
  • Resisted hand gripping using a dynamometer
  • Upper limb neurodynamic test-radial nerve bias (ULNDT-RN)
What rules you out
  • History of chronic pain conditions (e.g. fibromyalgia, irritable bowel
  • syndrome, temporomandibular dysfunction, migraines)
  • Neurological or sensory dysfunction (especially in the upper limbs)
  • History of chronic musculoskeletal pain (e.g. arthritis, chronic low back
  • pain)
  • Contraindications to cold application (i.e. Reynaud's disease, diabetes)
  • Current or long-term use of pain medication or anti-depressants Healthy Group The asymptomatic group included adults (18-65 years) without pain (acute or chronic) at least 3 months before the experimental sessions.

The study team makes the final eligibility decision.

Where it's taking place

  • Zarqa, Zarqa Governorate, Jordan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, up to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Zarqa, Zarqa Governorate, Jordan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.